Le Lézard
Classified in: Health
Subjects: NPT, AVO

American Diabetes Association® Celebrates Cockpit Doors Opening for People with Diabetes with Publication of New Federal Aviation Administration Protocol


ARLINGTON, Va., Nov. 7, 2019 /PRNewswire/ -- Today, the American Diabetes Association (ADA) applauds the Federal Aviation Administration (FAA) for announcing a protocol for pilots with insulin-treated diabetes to obtain the type of certificate needed for commercial flight. In 1959, the FAA banned pilots who use insulin from commercial operations, so today's move marks a historic day for people with diabetes.

"After many years of fighting for the rights of pilots with diabetes at every turn, we are pleased to have broken down a barrier that stood in place since 1959," said John Griffin, past chair of ADA's Board of Directors and member of ADA's Legal Advocacy Subcommittee. "Finally, children with diabetes are free to dream of growing up to be airline pilots."

ADA's position is that blanket bans against people with diabetes are never medically or legally appropriate. People with diabetes should always be given individual assessment of their qualifications and medical condition.

In 2010, the ADA began educating the FAA about the advances in diabetes medicine and treatment that make it possible to identify insulin-treated pilots who can safely fly. Over the course of the past decade, the ADA has continuously educated, negotiated with, and ultimately supported litigation all geared toward convincing the FAA that it is medically appropriate to grant individual assessment to commercial pilots treated with insulin. The ADA met with the FAA, brought industry stakeholders to the table, convened a panel of expert endocrinologists to provide recommendations, engaged members of Congress and filed friend-of-the-court briefs in litigation brought by pilots to challenge FAA inaction.

Today, thanks to the dedication of tireless ADA healthcare professional, attorney, and pilot volunteers and staff, the FAA has finished the work it promised pilots in 2015. Countless volunteers contributed to this victory, but in particular, former American Airlines Captain Eric Friedman, whose devotion to the cause of justice is extraordinary. Thanks to these volunteers and their sacrifices, people with diabetes have one fewer hurdle to overcome.

The ADA looks forward to working with the FAA to implement this protocol so that properly qualified insulin-treated pilots are granted medical certificates and eagerly awaits the day the first pilot treated with insulin is cleared to fly a commercial plane.

About the American Diabetes Association
Every day more than 4,000 people are newly diagnosed with diabetes in America. Nearly 115 million Americans have diabetes or prediabetes and are striving to manage their lives while living with the disease. The American Diabetes Association (ADA) is the nation's leading voluntary health organization fighting to bend the curve on the diabetes epidemic and help people living with diabetes thrive. For nearly 80 years the ADA has been driving discovery and research to treat, manage and prevent diabetes, while working relentlessly for a cure. We help people with diabetes thrive by fighting for their rights and developing programs, advocacy and education designed to improve their quality of life. Diabetes has brought us together. What we do next will make us Connected for Life. To learn more or to get involved, visit us at diabetes.org or call 1-800-DIABETES (1-800-342-2383). Join the fight with us on Facebook (American Diabetes Association), Twitter (@AmDiabetesAssn) and Instagram (@AmDiabetesAssn).

Contact: Alex Day, 703-253-4843
press@diabetes.org 

(PRNewsFoto/American Diabetes Association)

SOURCE American Diabetes Association


These press releases may also interest you

at 01:00
Ascentage Pharma (6855.HK), a global, clinical-stage biotechnology company developing novel therapies for cancers, chronic hepatitis B (CHB), and senesce diseases, today announced a clinical collaboration with MSD to evaluate the combination of...

at 00:00
Axios International, a global pioneering healthcare access company, has launched Axios+, a new generation of innovative digital solutions specifically designed to improve patient access and adherence to treatment. The solutions will support...

at 00:00
R3 International is now offering stem cell therapy for Alzheimers dementia in Mexico with a new program featuring up to 200 million stem cells. Depending on the patient's condition, treatment may be offered IV, intrathecal or with a combination. A...

5 jui 2020
HitGen Inc. (HitGen, 688222.SH) announced today that HitGen and Morphic Therapeutic have extended their drug discovery research collaboration to identify small molecule leads against targets specified by Morphic. HitGen's industry-leading DNA-encoded...

5 jui 2020
Everbright is pleased to confirm another large shipment of PPE arrived in Vancouver in June. Orders can be placed online for Authorized Medical Use KN95 Masks, ASTM Level 2 Surgical Masks, Disposable Face Masks, ANSI/AAMI Level 3 Surgical Gowns,...

5 jui 2020
The American Medical Veterinary Association (AVMA) interviewed Seth Wallack, DVM, Board Certified Veterinary Radiologist and Founder of Vetology® and Eric Goldman, President of Vetology® AI. Dr. Wallack and Eric Goldman discussed upcoming challenges...



News published on 7 november 2019 at 18:44 and distributed by: